ID   SEES6
AC   CVCL_RH10
SY   SEES-6; SEi-iku Embryonic Stem-6
DR   SKIP; SKIP001151
DR   Wikidata; Q54952780
RX   PubMed=31245438;
RX   PubMed=33225099;
CC   From: National Center for Child Health and Development (NCCHD); Tokyo; Japan.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
RX   PubMed=31245438; DOI=10.1016/j.reth.2014.12.004; PMCID=PMC6581821;
RA   Akutsu, Hidenori
RA   Machida, Masakazu
RA   Kanzaki, Seiichi
RA   Sugawara, Tohru
RA   Ohkura, Takashi
RA   Nakamura, Naoko
RA   Yamazaki-Inoue, Mayu
RA   Miura, Takumi
RA   Vemuri, Mohan C.
RA   Rao, Mahendra Surendra
RA   Miyado, Kenji
RA   Umezawa, Akihiro
RT   "Xenogeneic-free defined conditions for derivation and expansion of
RT   human embryonic stem cells with mesenchymal stem cells.";
RL   Regen. Ther. 1:18-29(2015).
//
RX   PubMed=33225099; DOI=10.31662/jmaj.2018-0029; PMCID=PMC7676987;
RA   Umezawa, Akihiro
RA   Sato, Yoji
RA   Kusakawa, Shinji
RA   Amagase, Rin
RA   Akutsu, Hidenori
RA   Nakamura, Kazuaki
RA   Kasahara, Mureo
RA   Matsubara, Yoichi
RA   Igarashi, Takashi
RT   "Research and development strategy for future embryonic stem
RT   cell-based therapy in Japan.";
RL   JMA J. 3:287-294(2020).
//